drugset / Trial / NCT04612465
Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula
RandomizedParallel-groupOpen-labelPrevention
Summary
This is a phase III study to evaluate the efficacy and safety of ASC(Autologous Adipose-derived Stem Cells) and Fibringlue or Fibringlue in Patients With Crohn's Fistula.
Timeline
- Start
- 2020-01-09
- Primary completion
- 2025-04-08
- Completion
- 2025-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | (Autologous Adipose-derived Mesenchymal Stem Cells) | Cell therapy | 1e+07 cells | — |
| Comparator | Fibrinogen Concentrate Human | Protein / enzyme biologic | — | — |